Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT03162588

Multiple Burrhole Therapy With Erythropoietin for Unstable Moyamoya

Feasibility Study of Multiple Burrhole Therapy Combined With Intravenous Erythropoietin Pretreatment for Unstable Moyamoya

Sponsor: Ajou University School of Medicine

Conditions Angiogenesis Burr Hole Ischemic Attack Ischemic Stroke Moyamoya Disease

Interventions erythropoietin

Updated 6 times since 2017 Last updated: Jun 19, 2017 Started: May 1, 2010 Primary completion: Sep 30, 2016 Completion: Sep 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Angiogenesis and Burr Hole and is currently completed. Ajou University School of Medicine leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1/PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

▶ Show 1 earlier version

Jul 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ajou University School of Medicine

Data source: Ajou University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Suwon, South Korea